Lochlabs Limited was incorporated in the year 2013 with core mandate of supply of medical, healthcare products and laboratories supplies. We have engaged in total quality services to ensure our esteemed customers get timely, cost effective and efficient services. We offer a broad range of diagnostic products for convenient and reliable testing used in hospitals, laboratories, clinics, and doctors’ offices as well as for self-testing at home. Most of our products are portable or hand held and user friendly.

We were  registered and licensed under Kenya Medical Laboratory Technicians & Technologists Board (KMLTTB) a body that provided regulation of the medical laboratory sciences practice in Kenya before Pharmacy and Poison Board ( PPB) was mandated with this role. We are fully registered as importers of medical devices products under Pharmacy and Poisons Board, a body that regulates the Practice of Pharmacy and the Manufacture and Trade in drugs and poisons in Kenya. We are bona fide member of Medical Technology Industry Association of Kenya (MEDAK) an industry trade association that represents medical devices in Kenya.

As at the year 2023 we are turning 10 years, we take pride of ourselves as among the key icons in the Kenyan medical devices market through our contribution to the healthcare sector by availing quality global diagnostics with a local touch and especially in the diabetes care. Over years, we have made progressive strides to command a substantial market share on diabetes care medical devices and In-vitro diagnostics for both dry and wet Chemistry. We are known in the region as the suppliers of Diabetes Care products and mostly with blood glucose monitoring system (Exactive Vital BGM) and other related laboratory Medical diagnostics.

In 2018 we re-focused to pursue 75% of our strategy, resources, capacity building and market development to diabetes care. This has since shown a positive trajectory ever since inception. Lochlabs Limited is a going concern entity whose focus and trajectory aims to command even higher market share in our area of jurisdiction or products line and services. In our expansion of products scope in the year 2022, we have roll out Continuous Glucose Monitoring System (CGM) and Insulin Pump business to compliment Blood Glucose Monitoring system (BGM) business that we have already explored for the last 10 years. This milestone marks a notable progress for us and in the region.